1. Home
  2. ACNB vs QTTB Comparison

ACNB vs QTTB Comparison

Compare ACNB & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACNB Corporation

ACNB

ACNB Corporation

HOLD

Current Price

$47.50

Market Cap

492.4M

Sector

Finance

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$6.95

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACNB
QTTB
Founded
1857
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.4M
44.3M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
ACNB
QTTB
Price
$47.50
$6.95
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$49.50
$13.00
AVG Volume (30 Days)
37.4K
231.8K
Earning Date
04-23-2026
03-10-2026
Dividend Yield
3.30%
N/A
EPS Growth
N/A
136.78
EPS
3.60
2.42
Revenue
$191,821,000.00
$53,737,000.00
Revenue This Year
$13.18
N/A
Revenue Next Year
$1.91
N/A
P/E Ratio
$12.85
$2.71
Revenue Growth
45.10
N/A
52 Week Low
$35.70
$1.38
52 Week High
$53.89
$7.80

Technical Indicators

Market Signals
Indicator
ACNB
QTTB
Relative Strength Index (RSI) 44.99 67.97
Support Level $42.84 $1.64
Resistance Level $49.13 $7.80
Average True Range (ATR) 1.42 0.80
MACD -0.10 0.08
Stochastic Oscillator 41.83 77.96

Price Performance

Historical Comparison
ACNB
QTTB

About ACNB ACNB Corporation

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Share on Social Networks: